Alkermes (ALKS) Gross Margin (2010 - 2026)
Alkermes (ALKS) reported Gross Margin of 80.38% for Q3 2026, down 6.54 percentage points from 86.91% a year earlier but up 0.16 percentage points from the prior quarter.
Alkermes (ALKS) Gross Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Alkermes' Gross Margin came in at 82.89%, down 3.16 percentage points year-over-year; for FY2025, it came in at 86.69%, up 2.44 percentage points from FY2024.
- Gross Margin has a five-year change of +3.86 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 84.25% in FY2024 (-0.54 pp), 84.79% in FY2023 (+4.40 pp), 80.39% in FY2022 (-2.80 pp) and 83.19% in FY2021 (+0.35 pp).
- Five-year quarterly Gross Margin spans a low of 78.87% in Q2 2022 and a high of 89.76% in Q2 2023.
- Year over year, Gross Margin gained in six of the last eight quarters, with an average year-over-year change of +0.04 percentage points.
- The high point for year-over-year Gross Margin in five years was Q2 2023 (a gain of 10.88 percentage points); the low point was Q2 2026 (a drop of 7.12 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 80.22% (Q2 2026), 84.33% (Q1 2026) and 87.98% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 75.71% |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn | 80.38% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 80.38% |
| Jun 30, 2026 | 80.22% |
| Mar 31, 2026 | 84.33% |
| Dec 31, 2025 | 87.98% |
| Sep 30, 2025 | 86.91% |
| Jun 30, 2025 | 87.34% |
| Mar 31, 2025 | 83.95% |
| Dec 31, 2024 | 85.55% |
| Sep 30, 2024 | 83.31% |
| Jun 30, 2024 | 84.60% |
| Mar 31, 2024 | 83.26% |
| Dec 31, 2023 | 81.42% |
| Sep 30, 2023 | 83.86% |
| Jun 30, 2023 | 89.76% |
| Mar 31, 2023 | 79.78% |
| Dec 31, 2022 | 82.30% |
| Sep 30, 2022 | 79.94% |
| Jun 30, 2022 | 78.87% |
| Mar 31, 2022 | 80.20% |
| Dec 31, 2021 | 83.47% |
Alkermes Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ALKS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();